Loading…
Pharmaceuticals · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 0.29% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Debt / 36-month avg market cap | 0.67% | < 33% | Pass |
| Cash + interest-bearing securities / 36-month avg market cap | 0.24% | < 33% | Pass |
| Accounts receivable / 36-month avg market cap | 0% | < 33% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free0.29% of any dividend from GRANULES should be given to charity. Calculate your amount →
GRANULES is in a strong uptrend with robust 3–6 month performance and trading close to its 52-week high. The price is supported by the 50-day being above the 200-day moving average.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.